MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
Why now
Thesis: Routine executive appointment, no investable signal
Catalyst to watch: None identifiable from the release
Main risk: Promotional personnel announcement
Why it matters
A general counsel appointment at a diabetes-tech firm is routine governance news.
Details
NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corporate Secretary. "Sheila brings deep board experience, strong regulatory and transactional judgment,...
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-28 13:03 UTC